GB201903953D0 - Oral GLP receptor agonists - Google Patents

Oral GLP receptor agonists

Info

Publication number
GB201903953D0
GB201903953D0 GBGB1903953.6A GB201903953A GB201903953D0 GB 201903953 D0 GB201903953 D0 GB 201903953D0 GB 201903953 A GB201903953 A GB 201903953A GB 201903953 D0 GB201903953 D0 GB 201903953D0
Authority
GB
United Kingdom
Prior art keywords
receptor agonists
oral glp
glp receptor
oral
agonists
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1903953.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nxera Pharma UK Ltd
Original Assignee
Heptares Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Heptares Therapeutics Ltd filed Critical Heptares Therapeutics Ltd
Priority to GBGB1903953.6A priority Critical patent/GB201903953D0/en
Publication of GB201903953D0 publication Critical patent/GB201903953D0/en
Ceased legal-status Critical Current

Links

GBGB1903953.6A 2019-03-22 2019-03-22 Oral GLP receptor agonists Ceased GB201903953D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB1903953.6A GB201903953D0 (en) 2019-03-22 2019-03-22 Oral GLP receptor agonists

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1903953.6A GB201903953D0 (en) 2019-03-22 2019-03-22 Oral GLP receptor agonists

Publications (1)

Publication Number Publication Date
GB201903953D0 true GB201903953D0 (en) 2019-05-08

Family

ID=66381528

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1903953.6A Ceased GB201903953D0 (en) 2019-03-22 2019-03-22 Oral GLP receptor agonists

Country Status (1)

Country Link
GB (1) GB201903953D0 (en)

Similar Documents

Publication Publication Date Title
IL282076A (en) Thyroid hormone receptor agonists
IL288921A (en) Melanocortin-4 receptor agonists
IL279300A (en) Glp-1 receptor agonists and uses thereof
IL279224A (en) Glp-1 receptor agonists and uses thereof
IL280290A (en) Il2 agonists
EP3650449A4 (en) Fxr receptor agonist
ZA202102263B (en) Oral formulations of kappa opioid receptor agonists
IL292601A (en) Npy2 receptor agonists
GB201911187D0 (en) Receptor
IL288536A (en) Il2 agonists
IL280199A (en) Receptor for vista
GB201816639D0 (en) GLP-1 Receptor Antagonist
GB201903951D0 (en) Oral GLP receptor agonists
GB201903953D0 (en) Oral GLP receptor agonists
GB201903900D0 (en) Adenosine receptor agonists
GB201816637D0 (en) Selective somatostatin receptor agonists
EP3904374A4 (en) T-cell receptor modified object
GB201903985D0 (en) GLP receptor agonists
GB202003766D0 (en) Oral GLP receptor agonists
GB202003764D0 (en) Oral GLP receptor agonists
GB202003762D0 (en) GLP receptor agonists
GB201817943D0 (en) Galanin-2 receptor agonists
GB201914767D0 (en) Linear apelin receptor agonists
GB201914756D0 (en) Cyclic apelin receptor agonists
GB201910515D0 (en) GLP-1 Receptor antagonists

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)